YAP1 Regulation of cardiomyocyte proliferation, function, and regeneration

YAP1 对心肌细胞增殖、功能和再生的调节

基本信息

  • 批准号:
    8412652
  • 负责人:
  • 金额:
    $ 56.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-02-01 至 2018-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Improved understanding of cardiac growth control mechanisms is needed to better treat heart disease, as abnormal cardiac growth underlies a subset of cardiomyopathies while inadequate postnatal cardiomyocyte proliferation poses a barrier to regenerative heart disease therapy. Emerging data indicate that the transcriptional co-regulator YAP1 is a fundamentally important regulator of cellular proliferation and organ size. Recent studies from our lab and others indicate that YAP1 critically regulates heart growth by promoting cardiomyocyte proliferation, including proliferation of trabecular and neonatal cardiomyocytes that are normally withdrawing from the cell cycle. Additional preliminary data indicate that YAP1 is essential for normal adult heart function. Intriguingly, we have also found that YAP1 binds plakoglobin, a human cardiomyopathy disease gene that forms cell adhesion junctions and that likely has additional activities in the nucleus. In this proposal we will expand on these results to gain insights into YAP1 regulation of cardiac growth, function, and regeneration. In the first aim, we will test the hypothesis that inhibitory Hippo kinase signaling upstream of YAP1 is required to limit excessive trabecular cardiomyocyte proliferation. In the second aim, we test the hypothesis that YAP1 mediates nuclear signaling by plakoglobin-containing cell adhesion junctions to regulate fetal heart growth and adult heart function. In the third aim, we test the hypothesis that YAP1 gain of function augments myocardial regeneration in myocardial injury models. Successful execution of these aims will inform efforts to improve heart function and stimulate myocardial regeneration.
描述(由申请人提供):需要提高对心脏生长控制机制的理解,以更好地治疗心脏病,因为心脏生长异常是心肌病的一部分,而出生后心肌细胞增殖不足是再生心脏病治疗的障碍。新出现的数据表明,转录共调节剂YAP1是细胞增殖和器官大小的重要调节剂。我们实验室和其他人最近的研究表明,YAP1通过促进心肌细胞增殖,包括正常退出细胞周期的小梁和新生儿心肌细胞的增殖,对心脏生长起到关键调节作用。其他初步数据表明,YAP1对正常成人心脏功能至关重要。有趣的是,我们还发现YAP1与血小板红蛋白结合,血小板红蛋白是一种人类心肌病基因,形成细胞粘附连接,可能在细胞核中有额外的活性。在这个建议中,我们将进行扩展

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Tswenching Pu其他文献

William Tswenching Pu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Tswenching Pu', 18)}}的其他基金

Desmosomes in cardiomyocyte homeostasis and disease
桥粒在心肌细胞稳态和疾病中的作用
  • 批准号:
    10606894
  • 财政年份:
    2022
  • 资助金额:
    $ 56.5万
  • 项目类别:
CMYA5 regulation of cardiac dyad structure and function
CMYA5对心脏二元体结构和功能的调节
  • 批准号:
    10607816
  • 财政年份:
    2022
  • 资助金额:
    $ 56.5万
  • 项目类别:
Genetic regulation of atrial gene expression in development and disease
发育和疾病中心房基因表达的遗传调控
  • 批准号:
    10576399
  • 财政年份:
    2021
  • 资助金额:
    $ 56.5万
  • 项目类别:
Genetic regulation of atrial gene expression in development and disease
发育和疾病中心房基因表达的遗传调控
  • 批准号:
    10355481
  • 财政年份:
    2021
  • 资助金额:
    $ 56.5万
  • 项目类别:
Regulation of Cardiomyocyte Maturation
心肌细胞成熟的调节
  • 批准号:
    9888413
  • 财政年份:
    2019
  • 资助金额:
    $ 56.5万
  • 项目类别:
Regulation of Cardiomyocyte Maturation
心肌细胞成熟的调节
  • 批准号:
    10334508
  • 财政年份:
    2019
  • 资助金额:
    $ 56.5万
  • 项目类别:
Enabling mammalian in vivo forward genetic screens based on cell morphology
实现基于细胞形态的哺乳动物体内正向遗传筛选
  • 批准号:
    9754850
  • 财政年份:
    2018
  • 资助金额:
    $ 56.5万
  • 项目类别:
Transcriptional regulation of arteriovenous differentiation
动静脉分化的转录调控
  • 批准号:
    9751955
  • 财政年份:
    2017
  • 资助金额:
    $ 56.5万
  • 项目类别:
Transcriptional regulation of arteriovenous differentiation
动静脉分化的转录调控
  • 批准号:
    9376461
  • 财政年份:
    2017
  • 资助金额:
    $ 56.5万
  • 项目类别:
2015 Weinstein Cardiovaascular Development Conference
2015年韦恩斯坦心血管发展大会
  • 批准号:
    8911591
  • 财政年份:
    2015
  • 资助金额:
    $ 56.5万
  • 项目类别:

相似海外基金

Understanding the Heightened Amputation Risk Among People Experiencing Homelessness: A Population-based Cohort Study
了解无家可归者截肢风险升高:一项基于人群的队列研究
  • 批准号:
    480010
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Operating Grants
Collaborative Research: An Integrated, Proactive, and Ubiquitous Prosthetic Care Robot for People with Lower Limb Amputation: Sensing, Device Designing, and Control
合作研究:针对下肢截肢患者的集成、主动、无处不在的假肢护理机器人:传感、设备设计和控制
  • 批准号:
    2246672
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Standard Grant
Collaborative Research: An Integrated, Proactive, and Ubiquitous Prosthetic Care Robot for People with Lower Limb Amputation: Sensing, Device Designing, and Control
合作研究:针对下肢截肢患者的集成、主动、无处不在的假肢护理机器人:传感、设备设计和控制
  • 批准号:
    2246671
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Standard Grant
Advancing measurement of physical function in upper limb amputation
推进上肢截肢身体功能的测量
  • 批准号:
    10749083
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
Collaborative Research: An Integrated, Proactive, and Ubiquitous Prosthetic Care Robot for People with Lower Limb Amputation: Sensing, Device Designing, and Control
合作研究:针对下肢截肢患者的集成、主动、无处不在的假肢护理机器人:传感、设备设计和控制
  • 批准号:
    2246673
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Standard Grant
Establishing the Relationship Between Muscle Quality and Joint Loading for Individuals with Transtibial Amputation
建立小腿截肢患者的肌肉质量和关节负荷之间的关系
  • 批准号:
    10677236
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
Preventing Amputation through Management of Diabetic Foot; Working with Industry to generate supply chains in an LMIC setting (Uganda) for low-cost fo
通过糖尿病足管理预防截肢;
  • 批准号:
    2883969
  • 财政年份:
    2023
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Studentship
Diabetes Lower Extremity Complications Research and Training Network in Foot Ulcer and Amputation Prevention (DIALECT)
糖尿病下肢并发症足部溃疡和截肢预防研究与培训网络 (DIALECT)
  • 批准号:
    EP/X02699X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Research Grant
Myoelectric upper limb prosthesis with multiple degrees of freedom using targeted muscle reinnervation surgery for traumatic amputation
多自由度肌电上肢假肢,采用靶向肌肉神经支配手术治疗创伤性截肢
  • 批准号:
    22K16723
  • 财政年份:
    2022
  • 资助金额:
    $ 56.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
An automatically-adjusting prosthetic socket for people with transtibial amputation
适用于小腿截肢患者的自动调节假肢接受腔
  • 批准号:
    10364108
  • 财政年份:
    2022
  • 资助金额:
    $ 56.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了